FDA Commissioner Dr. Marty Makary in Washington on July 29, 2025. Saul Loeb/AFP via Getty Images
The Food and Drug Administration will approve many new drugs based on one trial moving forward, agency leaders have said.
We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.
Read Full Article: https://www.theepochtimes.com/us/fda-dropping-requirement-for-2-studies-for-new-drug-approvals-5987549/?utm_source=partner&utm_campaign=whatfinger
